Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005;25(2):191-200.
doi: 10.1385/JMN:25:2:191.

Trafficking of adenosine A2A and dopamine D2 receptors

Maria Torvinen  1 , Carla Torri, Andrea Tombesi, Daniel Marcellino, Stan Watson, Carmen Lluis, Rafael Franco, Kjell Fuxe, Luigi F Agnati
Affiliations

Trafficking of adenosine A2A and dopamine D2 receptors

Maria Torvinen et al. J Mol Neurosci. 2005.

Abstract

An interaction between adenosine A2A and dopamine D2 receptors has been demonstrated previously. It is generally found that agonist treatment internalizes receptors, including A2A and D2, whereas less is known of the long-term effects involved in the agonist-mediated trafficking of A2A and D2 receptors. Furthermore, the possible influence of the antagonists on receptor trafficking is still undefined. The present studies focus on the long-term effects of A2A and D2 agonist and D2 antagonist treatments on both A2A and D2 receptor trafficking studied at three different time intervals--3, 15, and 24 h. In addition, with the fluorescence resonance energy transfer technique, formation of heteromeric A2A and D2 receptor complexes was shown in the cotransfected CHO cell line. Confocal microscopy analysis showed that a 3-h treatment with the D2 agonist induced coaggregation of A2A/D2 receptors. These A2A/D2 receptor coaggregates internalized after 15 h with a recruitment of the receptors back to the cell membrane after 24 h. In contrast to the effects of the agonist treatment, a 3-h treatment with the D2-like antagonist raclopride increased both A2A and D2 immunoreactivity, indicating that the D2 antagonist stabilizes the D2 receptor and thereby reduces the internalization of both of the A2A and D2 receptors. Taken together, an activation of either A2A and D2 receptor or blockade of D2 receptors will cause long-lasting changes in A2A and D2 receptor trafficking.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Biol Chem. 2003 Nov 21;278(47):46741-9 - PubMed
    1. Neurology. 2003 Dec 9;61(11 Suppl 6):S19-23 - PubMed
    1. FEBS Lett. 2002 Nov 6;531(2):245-9 - PubMed
    1. J Mol Neurosci. 2004;24(2):173-80 - PubMed
    1. Trends Biochem Sci. 2003 May;28(5):238-43 - PubMed

Publication types

MeSH terms

LinkOut - more resources

  NODES
INTERN 4
twitter 2